(Q40674329)

22 September 2017

title

Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-l-tyrosyl-p-aminobenzoic acid (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80139-5

17 June 2022

author name string

S. Nousia-Arvanitakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A305953

17 June 2022

C. Arvanitakis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A305953

17 June 2022

N. Desai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A305953

17 June 2022

N. J. Greenberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A305953

17 June 2022

language of work or name

English

0 references

publication date

1 May 1978

1 reference

full work available at URL

22 September 2017

https://api.elsevier.com/content/article/PII:S0022347678801395?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80139-5

https://api.elsevier.com/content/article/PII:S0022347678801395?httpAccept=text/plain

17 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80139-5

The Journal of Pediatrics

17 June 2022

published in

1 reference

22 September 2017

volume

92

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

734-737

1 reference

Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

A new prognostic score and clinical evaluation system for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

A method for the assay of chymotrypsin in crude biological materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

Stool trypsin and chymotrypsin. Value in the diagnosis of pancreatic insufficiency in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

Titrimetric measurements of fecal trypsin and chymotrypsin in cystic fibrosis with pancreatic exocrine insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

Nature of inhibition of ultraviolet erythema by pyribenzamine; preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980139-5

7 January 2021

Identifiers

1 reference

22 September 2017

1 reference